What is the current stock price of PixarBio Corporation (PXRB)?

As of the latest market data, PixarBio Corporation (PXRB) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does PixarBio Corporation (PXRB) pay a dividend?

Based on current data, PixarBio Corporation does not have a confirmed active dividend policy.

What is the market cap of PixarBio Corporation?

The current market capitalization of PixarBio Corporation (PXRB) is approximately unavailable.

PXRB

PixarBio Corporation·Consumer Cyclical

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.

Sector

Consumer Cyclical

Industry

Personal Products & Services

Employees

IPO Date

2023-06-27

Beta

-55.70